Partly unequal receipt of healthcare in last month of life in amyotrophic lateral sclerosis: a retrospective cohort study of the Stockholm region
Abstract
Context: In amyotrophic lateral sclerosis (ALS), equal care is important, given that the disease often has complex symptoms at the end of life.
Objectives: The aim was to study the possible associations between demographic and clinical factors, including age, sex, and frailty, with acute healthcare utilization in the last month of life, measured by emergency room (ER) visits, admissions to acute hospitals and, acute hospitals as place of death, among patients with ALS. A second aim was to study whether receipt of specialized palliative care (SPC) affects above-mentioned healthcare utilization.
Methods: Observational, retrospective study based on Region Stockholm’s administrative data warehouse (VAL) in Sweden. Data were retrieved for 2015–2021 and analyzed with descriptive statistics and logistic regression models.
Results: All deceased patients (n = 448) ≥18 years with ALS were included. The mean age was 70.5 years, 46% were women and 58% had risk of frailty according to Hospital Frailty Risk Score (HFRS). Ninety-nine (22%) were nursing home residents and 49% received SPC. The receipt of SPC in patients with ALS was equal in relation to gender, socio-economic standing, frailty, and age <75 years. Patients ≥75 years, those with dementia and/or residing in nursing homes (NH) were less likely to receive SPC (P = 0.01, P = 0.03 and P = 0.002, respectively). Receipt of SPC reduced ER visits (29% vs. 48%, P < 0.001) and deaths at hospital (12% vs. 48%, P <0.001). Patients who were frail, had a higher risk of ER visits and were more likely to die at an acute hospital setting (P < 0.001 and P = 0.004). NH residents were less likely to have ER visits and to die in hospital (P = 0.002 and P = 0.005).
Conclusions: The results indicate partly unequal distribution of palliative care, however the actual, individual preferences cannot be deducted from registry studies. All patients with ALS should be offered SPC when needed.
Key message: This register study shows that receipt of SPC in patients with ALS is equal in relation to gender, socioeconomic standing, frailty, and age <75 years, while those ≥75 years, with dementia, or residing in NH were somewhat less likely to receive SPC. Receipt of SPC reduces ER visits and acute hospital admissions.
Downloads
References
2. Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:649–54. doi: 10.1097/WCO.0000000000000862
3. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75. doi: 10.1111/j.1468-1331.2011.03501.x
4. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3
5. Sennfält S, Kläppe U, Thams S, Samuelsson K, Press R, Fang F, et al. Dying from ALS in Sweden: clinical status, setting, and symptoms. Amyotroph Lateral Scler Frontotemporal Degener. 2022;24:237–245. doi: 10.1080/21678421.2022.2096411
6. Eljas Ahlberg E, Axelsson B. End-of-life care in amyotrophic lateral sclerosis: a comparative registry study. Acta Neurol Scand. 2021;143:481–8. doi: 10.1111/ane.13370
7. Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248: 612–6. doi: 10.1007/s004150170140
8. Ozanne A, Sawatzky R, Håkanson C, Alvariza A, Fürst CJ, Årestedt K, et al. Symptom relief during last week of life in neurological diseases. Brain Behav. 2019;9:e01348. doi: 10.1002/brb3.1348
9. van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JM, van den Berg LH, Schröder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14:107. doi: 10.1186/s12955-016-0507-6
10. Larsson BJ, Ozanne A, Nordin K, Nygren I. Quality of life among relatives of patients with amyotrophic lateral sclerosis: a prospective and longitudinal study. Palliat Support Care. 2022;20:203–11. doi: 10.1017/S1478951521000778
11. Ozanne AO, Graneheim UH, Strang S. Struggling to find meaning in life among spouses of people with ALS. Palliat Support Care. 2015;13: 909–16. doi: 10.1017/S1478951514000625
12. Ozanne AO, Graneheim UH, Strang S. Finding meaning despite anxiety over life and death in amyotrophic lateral sclerosis patients. J Clin Nurs. 2013;22:2141–9. doi: 10.1111/jocn.12071
13. Olsson AG, Markhede I, Strang S, Persson LI. Differences in quality of life modalities give rise to needs of individual support in patients with ALS and their next of kin. Palliat Support Care. 2010;8:75–82. doi: 10.1017/S1478951509990733
14. Sethi A, Everett E, Mehta A, Besbris J, Burke C, Pedowitz E, et al. The role of specialty palliative care for amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2022;39:865–73. doi: 10.1177/10499091211049386
15. Veronese S, Gallo G, Valle A, Cugno C, Chiò A, Calvo A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care. 2017;7:164–72. doi: 10.1136/bmjspcare-2014-000788
16. Mandler RN, Anderson FA Jr., Miller RG, Clawson L, Cudkowicz M, Del Bene M. The ALS patient care database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:203–8. doi: 10.1080/14660820152882214
17. Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122:217–23. doi: 10.1111/j.1600-0404.2009.01290.x
18. Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62. doi: 10.1080/17482960701656940
19. Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51. doi: 10.1111/j.1468-1331.2008.02307.x
20. Goutman SA, Nowacek DG, Burke JF, Kerber KA, Skolarus LE, Callaghan BC. Minorities, men, and unmarried amyotrophic lateral sclerosis patients are more likely to die in an acute care facility. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:440–3. doi: 10.3109/21678421.2014.924143
21. Nordström M, Strang P. High degree of satisfaction with the support given by multidisciplinary palliative home care teams in the County of Stockholm. J Palliat Care. 2018;33:109–14. doi: 10.1177/0825859718759880
22. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18:805–35. doi: 10.1097/EDE.0b013e3181577511
23. Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391:1775–82. doi: 10.1016/S0140-6736(18)30668-8
24. Strang P, Fürst P, Schultz T. Excess deaths from Covid-19 correlate with age and socioeconomic status. A database study in the Stockholm region. Ups J Med Sci. 2020;124:297–304. doi: 10.1080/03009734.2020.1828513
25. InsightOne. Experia MIS MosaicTM Sweden. Stockholm: Experian; 2015.
26. riksdag S. Hälso- och sjukvårdslag (2017:30) 2022. Available from: https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/halso--och-sjukvardslag-201730_sfs-2017-30 [cited 6 June 2022].
27. samverkan Rci. Nationellt vårdprogram palliativ vård 2021. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/palliativ-vard/vardprogram/ [cited 7 June 2022].
28. Strang P, Furst P, Hedman C, Bergqvist J, Adlitzer H, Schultz T. Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths. BMC Pulm Med. 2021;21:170. doi: 10.1186/s12890-021-01533-3
29. Henoch I, Ekberg-Jansson A, Löfdahl CG, Strang P. Benefits, for patients with late stage chronic obstructive pulmonary disease, of being cared for in specialized palliative care compared to hospital. A nationwide register study. BMC Palliat Care. 2021;20:130. doi: 10.1186/s12904-021-00826-y
30. Elmstedt S, Mogensen H, Hallmans DE, Tavelin B, Lundström S, Lindskog M. Cancer patients hospitalised in the last week of life risk insufficient care quality – a population-based study from the Swedish Register of Palliative Care. Acta Oncol. 2019;58:432–8. doi: 10.1080/0284186X.2018.1556802
31. Hedman C, Strang P, Lundström S, Martinsson L. Symptom management and support in dying patients with cancer and coronavirus disease-19-a register-based study. J Palliat Care. 2023;38:261–7. doi: 10.1177/08258597231157622
32. Strang P, Schultz T. Dying with cancer and COVID-19, with special reference to lung cancer: frailty as a risk factor. Cancers (Basel). 2022;14: 6002. doi: 10.3390/cancers14236002
33. Strang P, Schultz T. The impact of frailty on palliative care receipt, emergency room visits and hospital deaths in cancer patients: a registry-based study. Curr Oncol. 2023;30:6623–33. doi: 10.3390/curroncol30070486
34. Broussalis E, Grinzinger S, Kunz AB, Killer-Oberpfalzer M, Haschke-Becher E, Hartung HP, et al. Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people. Acta Neurol Scand. 2018; 137:329–34. doi: 10.1111/ane.12869
35. Lindskog M, Schultz T, Strang P. Acute healthcare utilization in end-of-life among Swedish brain tumor patients – a population based register study. BMC Palliat Care. 2022;21:133. doi: 10.1186/s12904-022-01022-2
36. Bergqvist J, Hedman C, Schultz T, Strang P. Equal receipt of specialized palliative care in breast and prostate cancer: a register study. Support Care Cancer. 2022;30:7721–30. doi: 10.1007/s00520-022-07150-y
37. Furst P, Schultz T, Strang P. Specialized palliative care for patients with chronic heart failure at end of life: transfers, emergency department visits, and hospital deaths. J Palliat Med. 2022. doi: 10.1089/jpm.2022.0292
38. Kläppe U, Longinetti E, Larsson H, Ingre C, Fang F. Mortality among family members of patients with amyotrophic lateral sclerosis – a Swedish register-based study. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:226–35. doi: 10.1080/21678421.2021.1953075
39. Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. Palliative care issues in amyotrophic lateral sclerosis: an evidenced-based review. Am J Hosp Palliat Care. 2016;33:84–92. doi: 10.1177/1049909114548719
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Upsala Medical Society. Read the full Copyright- and Licensing Statement.
